Addressing SARS-CoV-2 evolution: neutralization of emerging variants of concern by the AVX/COVID-12 ‘Patria’ vaccine based on HexaPro-S ancestral Wuhan spike or its updated BA.2.75.2 version

These findings underscore the adaptability of NDV-based platforms in addressing the evolving SARS-CoV-2 landscape and reaffirm the ongoing utility of the ancestral Patria vaccine. Together, they demonstrate the potential of these platforms to drive the development of next-generation vaccines tailored to emerging viral threats, contributing to global health equity.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2025-05-19
DOI
https://doi.org/10.3389/fimmu.2025.1565934
Citations
2
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
2.79

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Addressing SARS-CoV-2 evolution: neutralization of emerging variants of concern by the AVX/COVID-12 ‘Patria’ vaccine based on HexaPro-S ancestral Wuhan spike or its updated BA.2.75.2 version

Bernardo Lozano-Dubernard, Weina Sun, Gabriela Mellado‐Sánchez, Peter Palese et al.
2 citations
Frontiers in Immunology
SARS-CoV-2 and COVID-19 Research
2.79
article

Addressing SARS-CoV-2 evolution: neutralization of emerging variants of concern by the AVX/COVID-12 ‘Patria’ vaccine based on HexaPro-S ancestral Wuhan spike or its updated BA.2.75.2 version

Bernardo Lozano-Dubernard, Weina Sun, Gabriela Mellado‐Sánchez, Peter Palese, Adolfo Garcı́a-Sastre, Keyla Gómez-Castellano, Héctor Elías Chagoya-Cortés, Georgina Paz-De la Rosa, David Sarfati-Mizrahi, Oscar Rojas-Martínez, Constantino López-Macı́as, Juana Salinas-Trujano, Sonia Mayra Pérez‐Tapia, Gustavo Peralta-Sánchez, Jesús Horacio Lara-Puente, Juan C. Almagro, Milagros Salazar, Gregorio Carballo‐Uicab, Jesús Torres-Flores, Florian Krammer, Ignacio Mena, Ivette Mendoza-Salazar, Edith González‐González, Alejandro Torres-Flores, Karina López-Olvera
article en
2 citations

Abstract

These findings underscore the adaptability of NDV-based platforms in addressing the evolving SARS-CoV-2 landscape and reaffirm the ongoing utility of the ancestral Patria vaccine. Together, they demonstrate the potential of these platforms to drive the development of next-generation vaccines tailored to emerging viral threats, contributing to global health equity.

Frontiers in ImmunologyVol. 16
Semmelweis University (HU), Mexican Social Security Institute (MX), Mexican Geological Survey (MX), Consejo Nacional de Ciencia y Tecnología (PY), Universidad Mexicana (MX), Centro Medico Nacional Siglo XXI (MX), Hospital de Especialidades (MX), Instituto Politécnico Nacional (MX), Icahn School of Medicine at Mount Sinai (US)
Institute of Nuclear Energy Research
No poverty
Openalex Percentile: Top 11%
SARS-CoV-2 and COVID-19 Research
2.79
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.